Teva Pharmaceutical Industries and AbbVie’s Allergan unit on Tuesday reached a $58m settlement with the United States city of San Francisco just before completion of a trial over claims that they fuelled an opioid epidemic in the city.Under the deal announced by City Attorney of San Francisco David Chiu, Israel-based Teva will pay $25m in cash and contribute a $20m supply of the overdose-reversal drug Narcan. AbbVie will pay $13m.“This will bring significant resources to help with education, prevention and treatment, and the addition of tens of millions of dollars worth of overdose reversal medication will save lives in the Bay Area,” said Paul Geller, a lawyer who represented the city in negotiating the settlement.
Load More
Load More